Kezar Life Sciences, Inc. (KZR): Price and Financial Metrics
KZR Price/Volume Stats
| Current price | $7.49 | 52-week high | $11.35 |
| Prev. close | $7.38 | 52-week low | $5.20 |
| Day low | $7.45 | Volume | 107,200 |
| Day high | $7.58 | Avg. volume | 73,943 |
| 50-day MA | $7.31 | Dividend yield | N/A |
| 200-day MA | $7.43 | Market Cap | 54.65M |
KZR Stock Price Chart Interactive Chart >
Kezar Life Sciences, Inc. (KZR) Company Bio
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of small molecule therapeutics to treat unmet needs in autoimmunity and cancer in the United States. Its lead product candidate, KZR-616, a selective immunoproteasome inhibitor that is in Phase 1b/2 clinical trials in lupus and lupus nephritis The company was incorporated in 2015 and is headquartered in South San Francisco, California.
KZR Price Returns
| 1-mo | -3.97% |
| 3-mo | 19.13% |
| 6-mo | 6.24% |
| 1-year | -17.87% |
| 3-year | -94.79% |
| 5-year | -73.90% |
| YTD | -20.94% |
| 2023 | -86.54% |
| 2022 | -57.89% |
| 2021 | 220.31% |
| 2020 | 30.17% |
| 2019 | -83.01% |
Loading social stream, please wait...